Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2866 in women with moderate to severe chronic obstructive pulmonary disease undergoing pulmonary rehabilitation
2009-014657-32Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic obstructive pulmonary disease (COPD) and muscle atrophy comparing MK-2866 with Placebo (2 arms). Primary endpoint: Lower extremity muscle strength. Started Sep 2009; status: terminated.
02
Drugs
enobosarm
03
Conditions
chronic obstructive pulmonary disease (COPD)muscle atrophy
Beyond the preview
Go deeper on 2009-014657-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014657-32.